Agalsidase beta No Longer Available Phase N/A Trials for Fabry's Disease

IndicationsStatusPurposePhase
No Longer AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01031173Treatment Protocol of Replagal for Patients With Fabry Disease